Latest Articles
-
Trump Presidency: Risk or Non-Issue For First Solar?
First Solar stock (NASDAQ:FSLR) has fared much better than its sector peers, rising by about 13% year-to-date. In comparison, Enphase Energy stock (NASDAQ:ENPH), another solar component player, has seen its stock decline by 38% over the same peri...
-
A Deep Dive Into Amazon Stock Risks And Opportunities
Amazon stock (NASDAQ: AMZN) has fared well this year, rising by over 30% so far. At its current market of just under $200, the stock is trading roughly 5% below its fair value of $210 – the Trefis estimate for Amazon’s valuation . In th...
-
Guidance Misses, But AMD Delivers Where It Counts
Advanced Micro Devices stock (NASDAQ: AMD) stock dropped about 13% over the past two trading days, following its Q3 earnings report, during which the company provided slightly softer-than-expected guidance for the upcoming quarter. AMD forecast...
-
Why FCX Stock Hasn’t Gained Much From Record Gold Prices?
Freeport-McMoRan (NYSE: FCX), one of the largest producers of copper, has seen its stock underperform over the last month, falling by 8% compared to the S&P 500 which was up 1%. Does this come as a surprise at a time when gold realizations ...
-
Why Ford Stock Looks Attractive At $10
Ford stock (NYSE:F) fell by close to 8% on Tuesday, following the company’s Q3 earnings report. Now revenues were better than expected coming in at $43 billion, up 5.5% year-over-year, earnings stood at $0.49 per share, slightly ahead of es...
-
Can Harley Stock Bounce Back Despite Tough Earnings?
Harley-Davidson stock (NYSE:HOG) currently trades at about $33 per share, around 33% below its levels of $49 seen on May 17, 2021 (pre-inflation shock high), and appears to be undervalued. Harley saw its stock trading at around $30.50 at the e...
-
Why Did Eli Lilly Stock Fall 6%?
Eli Lilly stock (NYSE: LLY) fell over 6% on Wednesday, October 30, after it posted downbeat results. The company reported revenue of $11.4 billion and adjusted earnings of $1.18 per share, well below the consensus estimates of $12.1 billion and...
-
Netflix Stock Downside Scenario: $400
Netflix (NASDAQ:NFLX) stock has had a solid year, rising by almost 60% year-to-date as the company successfully navigated a brief subscriber decline post-Covid-19. This compares to rival Disney (NYSE:DIS), which has gained a mere 5% over the same...
-
What’s Happening With FFIV Stock?
F5 stock (NASDAQ: FFIV) was up 10% on Tuesday, October 29, after the company posted upbeat Q4 results and a better than anticipated guidance for 2025. It posted revenue of $747 million and adjusted earnings of $3.67 per share, compared to the c...
-
Time To Snap Up SNAP Stock?
Snap’s stock (NYSE: SNAP) surged over 10% in after market hours on Tuesday, October 29, after the company posted upbeat Q3 results. Snap reported revenue of $1.37 billion and adjusted earnings of eight cents per share – faring better than...
-
DR Horton & Pulte Group: What’s Happening With Home Builder Stocks?
Our theme of Housing Stocks, which includes the stocks of home improvement players, building supply companies, and home builders including DR Horton (NYSE:DHI) and Pulte Group (NYSE:PHM) has gained about 23% year-to-date. This is roughly in lin...
-
Super Micro Computer Stock: High Risk, Higher Upside?
Super Micro Computer stock (NASDAQ: SMCI) has experienced considerable volatility this year. Super Micro Computer is a data center solutions provider, which sells server systems, server boards, storage, networking solutions, management software,...
-
Mounjaro To Lead Eli Lilly’s Q3 Growth
Eli Lilly stock (NYSE: LLY) will report its Q3 results on Wednesday, October 30. The pharmaceutical giant is expected to garner $12.1 billion in sales and $1.45 in adjusted earnings per share, per the consensus estimates. All eyes will be on El...
-
Caterpillar Sales To Trend Lower In Q3
Caterpillar (NYSE: CAT) will report its Q3 2024 results on Wednesday, October 30. We expect the company’s revenues to come in at $16.2 billion and adjusted earnings of $5.36 per share, broadly aligning with the consensus estimates. The company ...
-
Why Did Monopar Stock Swing So Wildly Last Week?
The stock price of Monopar Therapeutics (NASDAQ: MNPR), a clinical-stage biopharmaceutical company, skyrocketed from levels of $5.25 on Monday, October 21, to $32.66 on Thursday, October 24, before falling to around $17 now. The 6x rise in a matt...
